Endocrine News

On September 17, members of the Endocrine Society joined advocates from around the country to call on Congress to provide increased funding for biomedical research as part of the 13th annual Rally for Medical Research.

Lisa B. Nachtigall, MD, has built her career around the kind of medicine that extends far beyond the exam room: caring for patients with complex endocrine disorders, advocating for those with rare diseases, and helping inspire the next generation of endocrinologists. In recognition of her extraordinary contributions to clinical practice and the endocrine community, the Endocrine Society selected Nachtigall as a 2026 Laureate recipient of the Vigersky Outstanding Clinical Practitioner Award.

Neuroendocrine neoplasms (NENs) can show up anywhere in the body and can impact any organ system. These tumors originate in diverse sites, according to the authors of a recently published paper in Endocrine Reviews, which kind of makes them moving targets. Authors of the paper, “Epigenetics and disease progression in neuroendocrine neoplasms,” led by Madson Q.

On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome. Emcitate is the first therapy approved by the FDA to treat symptoms of this very rare, devastating genetic disease.

All of the sessions at ENDO 2026 in Chicago proved to be a big hit. But certain sessions cause a little bit more buzz than others and one of those was part of the Professional Development tract called “Reframing Failure” which explored the process of regaining momentum after significant professional challenges.

Women make up more than half of the U.S. population, yet too often their health needs are ignored or minimized. On Sept. 29, the Endocrine Society’s staff joined representatives from the Society for Women’s Health Research (SWHR), the American College of Obstetricians & Gynecologists (ACOG), and the Women First Research Coalition (WFRC), and other representatives of the endorsing organizations on Capitol Hill to support the National Strategy to Close the Women’s Health Gap.

For endocrinologists, an electronic health record (EHR) has to do more than house patient charts. The right platform can help clinicians follow years of laboratory trends, manage diabetes technology data, monitor medications and hormone therapies, streamline prior authorizations, communicate with patients, and coordinate care across specialties.

Nobody reading this has not been affected one way or another by cancer; whether you treat patients or conduct research. Or, more personally, if you have a loved one diagnosed or you’ve experienced cancer yourself, then you have more firsthand experience than you care to. In this month’s issue we are going to focus on a number of endocrine-specific cancers, their treatments, and the solid amount of research that scientists have invested in looking for potential therapies or even cures.

Researchers in Brazil recently published a paper in JCEM Case Reports, detailing a 22-year-old man who developed am acute adrenal crisis following bitalteral orchiectomy for testicular tumors.

This is a good one, what endocrinology is all about: true detectives. In April 2025, JCEM Case Reports published an article titled, “Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma,” describing the case of a 52-year-old male who presented with cerebrospinal fluid rhinorrhea and was found to have an invasive, 4.2-cm pituitary mass with modestly elevated prolactin.